RxDoctor Payments Data

Holly Austin, PA

Physician Assistant · Clarksville, TNNPI 1437403144

Payments from drug & device makers

$1,749in general payments, 2019–2025

Across 86 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$582
  • AstraZeneca$312
  • Lilly USA, LLC$206
  • Sanofi-aventis U.S. LLC$149
  • AbbVie$119
  • Amgen$62
  • plus $319 from 13 others

What the payments were for

  • Food & beverage$1,749100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,749 in reported general payments places this provider in the 75th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$44,474
Medicare patients
206
Services billed
1,151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$107,516
MounjaroTirzepatide61$64,482
JardianceEmpagliflozin40$34,101
EliquisApixaban42$28,466
TrulicityDulaglutide24$23,289
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$21,581
JanuviaSitagliptin Phosphate21$20,211
WegovySemaglutide13$18,369
FarxigaDapagliflozin Propanediol15$13,825
XareltoRivaroxaban17$11,902
Breo ElliptaFluticasone/Vilanterol12$4,883
Lantus SolostarInsulin Glargine,hum.Rec.Anlog38$3,137
PremarinEstrogens, Conjugated11$2,236
Albuterol Sulfate HfaAlbuterol Sulfate129$2,098
Levothyroxine Sodium179$1,738

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$582$125,88679 claims
Lilly USA, LLCMounjaro, Trulicity$206$87,77185 claims
AstraZenecaBreztri Aerosphere, Farxiga$312$35,40638 claims
MerckJanuvia$36$20,21121 claims
Johnson & JohnsonXarelto$17$11,90217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Clarksville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →